APA (7th ed.) Citation

H, X., G, Y., X, G., Q, L., J, Z., X, G., . . . G, L. (2016). A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway. Autophagy, 12(7), 1129. https://doi.org/10.1080/15548627.2016.1178446

Chicago Style (17th ed.) Citation

H, Xue, et al. "A Novel Tumor-promoting Mechanism of IL6 and the Therapeutic Efficacy of Tocilizumab: Hypoxia-induced IL6 Is a Potent Autophagy Initiator in Glioblastoma via the P-STAT3-MIR155-3p-CREBRF Pathway." Autophagy 12, no. 7 (2016): 1129. https://doi.org/10.1080/15548627.2016.1178446.

MLA (9th ed.) Citation

H, Xue, et al. "A Novel Tumor-promoting Mechanism of IL6 and the Therapeutic Efficacy of Tocilizumab: Hypoxia-induced IL6 Is a Potent Autophagy Initiator in Glioblastoma via the P-STAT3-MIR155-3p-CREBRF Pathway." Autophagy, vol. 12, no. 7, 2016, p. 1129, https://doi.org/10.1080/15548627.2016.1178446.